Suchergebnisse - "Buti, Maria"

PubPharm (298)

1

Viral Load Measurements in Individuals with Hepatitis C Virus Infection : on the European Association for the Study of the Liver Recommendations on Treatment of Hepatitis C 2018

enthalten in: Journal of clinical microbiology | 2019

von Rando-Segura, A. | Buti, M. | Quer, J. | +2

2

Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)

enthalten in: Revista espanola de enfermedades digestivas | 2019

von Crespo, J. | Albillos, A. | Buti, M. | +24

3

Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference

enthalten in: Hepatology (Baltimore, Md.) | 2019

von Cornberg, M. | Lok, A. | Terrault, N. | +25

4

Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)

enthalten in: Gastroenterologia y hepatologia | 2019

von Crespo, J. | Albillos, A. | Buti, M. | +24

5

Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2019

von Marcellin, P. | Wong, D. | Sievert, W. | +14

6

Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs

enthalten in: Journal of hepatology | 2019

von Llaneras, J. | Riveiro-Barciela, M. | Lens, S. | +30

7

Efficacy and safety of a two-drug direct-acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6

enthalten in: Journal of viral hepatitis | 2019

von Lawitz, E. | Gane, E. | Feld, J. | +56

8

Factors influencing hepatitis C cure in the era of direct-acting antivirals

enthalten in: Gastroenterologia y hepatologia | 2019

von Castellote, J. | Gea, F. | Morano, L. | +4

9

Too many people with viral hepatitis are diagnosed late - with dire consequences

enthalten in: Nature reviews. Gastroenterology & hepatology | 2019

von Lazarus, J. | Picchio, C. | Dillon, J. | +3

10

Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B : results from the SONIC-B study

enthalten in: The lancet. Gastroenterology & hepatology | 2019

von Sonneveld, M. | Brouwer, W. | Chan, H. | +13

CommentIn: Lancet Gastroenterol Hepatol. 2019 Jul;4(7):495-496. - PMID 30975476

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[30]